Evidence map›Paper›PMID 29710777›Full record

ReviewNutrients2018

Egg and Soy-Derived Peptides and Hydrolysates: A Review of Their Physiological Actions against Diabetes and Obesity.

Stepheny C de Campos Zani, Jianping Wu, Catherine B Chan

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in Nutrients, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05282641 (Effects of 10-gram Collagen Protein Hydrolysate on Cardiometabolic Health in Obese), which is not on this map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05282641 nacompletednot on this mapstarted 2021, after this paper: background citation

Effects of 10-gram Collagen Protein Hydrolysate on Cardiometabolic Health in Obese (BMI 25-35 kg/m2) Men and Women With Elevated Risk to Develop Type-2 Diabetes and CVD

TypeinterventionalSponsorMaastricht University Medical CenterRan2021 to 2023Enrolled63ConditionsGlucose Metabolism, Lipid MetabolismArms10 g of collagen hydrolysate, Placebo
3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 66 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Exploitation of Olive (Antioxidants (Basel, Switzerland) · 2022
    Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Exploring the Role of a Novel Peptide fromInternational journal of molecular sciences · 2020
    Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Stepheny C de Campos ZaniDepartment of Physiology, University of Alberta, Edmonton, AB T6G 2R3, Canada. zani@ualberta.ca.
Jianping WuDepartment of Agricultural, Food & Nutritional Science, University of Alberta, Edmonton, AB T6G 2R3, Canada. jwu3@ualberta.ca.
Catherine B ChanDepartment of Physiology, University of Alberta, Edmonton, AB T6G 2R3, Canada. cbchan@ualberta.ca.ORCID 0000-0003-3882-0592
University of Alberta · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Type 2 diabetes and obesity are two chronic conditions associated with the metabolic syndrome and their prevalences are increasing worldwide. The investigation of food protein-derived bioactive peptides that can improve the pathophysiology of diabetes or obesity while causing minimal side effects is desired. Egg and soy proteins generate bioactive peptides with multiple biological effects, exerting nutritional and physiological benefits. This review focuses on the anti-diabetic and anti-obesity effects of egg- and soy-derived peptides and hydrolysates in vivo and in vitro relevant to these conditions. Studies using the intact protein were considered only when comparing the results with the hydrolysate or peptides. In vivo evidence suggests that bioactive peptides from egg and soy can potentially be used to manage elements of glucose homeostasis in metabolic syndrome; however, the mechanisms of action on glucose and insulin metabolism, and the interaction between peptides and their molecular targets remain unclear. Optimizing the production of egg- and soy-derived peptides and standardizing the physiological models to study their effects on diabetes and obesity could help to clarify the effects of these bioactive peptides in metabolic syndrome-related conditions.

Indexed as

AnimalsAnti-Obesity AgentsBiomarkersBlood GlucoseDiabetes Mellitus, Type 2Egg Proteins, DietaryHumansHypoglycemic AgentsInsulinInsulin ResistanceMetabolic SyndromeObesityProtein HydrolysatesSoybean ProteinsAnti-Obesity AgentsBiomarkersBlood GlucoseEgg Proteins, DietaryHypoglycemic AgentsInsulinProtein HydrolysatesSoybean Proteinsbioactive peptidesdiabetesegghydrolysateobesitypeptidessoy

Identifiers

PMID29710777
PMCPMC5986429
OpenAlexW2801910341

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.